Royal Bank of Canada
STSA

Royal Bank of Canada’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Royal Bank of Canada’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-93
Closed – – 7979
2022
Q1 		$0 Buy
+93
New +$419 ﹤0.01% 8176
2021
Q3 		– Sell
-1,774
Closed -$13K – 7997
2021
Q2 		$13K Buy
1,774
+538
+44% +$2.9K ﹤0.01% 6786
2021
Q1 		$7K Buy
1,236
+249
+25% +$1.51K ﹤0.01% 6968
2020
Q4 		$5K Buy
+987
New +$4.25K ﹤0.01% 6682
2020
Q3 		– Sell
-12
Closed – – 7068
2020
Q2 		$0 Sell
12
-309
-96% -$7.15K ﹤0.01% 7027
2020
Q1 		$6K Buy
321
+20
+7% +$454 ﹤0.01% 6004
2019
Q4 		$6K Buy
+301
New +$4.28K ﹤0.01% 6319

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's STSA Position: Q2 2022 in Review

Royal Bank of Canada sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2022, closing a stake of 93 shares.

Royal Bank of Canada first reported a position in STSA in Q4 2019 and held it in 7 quarters. The position peaked at $13K in Q2 2021. 32 funds tracked by Wall St. Rank hold STSA as of Q2 2022.

  • Royal Bank of Canada reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 93 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2022.
  • Royal Bank of Canada first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Royal Bank of Canada's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $13K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.